As a small, highly-leveraged company that must compete with brand-name goliaths such as Clorox (NYSE:CLX), Procter & Gamble (NYSE:PG) and Unilever (NYSE:UL) on a daily basis, it's not altogether surprising that Helen Of Troy (Nasdaq:HELE) shares can be very volatile. Today's poor growth numbers are certainly a concern, as are the company's long-term market position and cash flow leverage, but aggressive investors may see opportunity emerging in a company that has often been knocked down, only to rise once again.

Investopedia Broker Guide: Enhance your trading with the tools from today's top online brokers.

A Disappointing Fiscal Second Quarter
Helen of Troy's fiscal first quarter was also disappointing, and at the time I mentioned that I thought management's guidance for the year seemed optimistic. Apparently that is so, as sales look weak, and management has lowered full-year profit expectations.

Reported sales rose less than 4% this quarter, not only missing the average analyst estimate by 4%, but also showing marked deceleration from the double-digit growth of the fiscal first quarter. Revenue rose a reported 1% in housewares and more than 12% in healthcare/home environment, but fell more than 2% in personal care.

In point of fact, however, performance was worse. Stripping out the revenue tied to PUR (which the company bought from Procter & Gamble last year), organic revenue actually declined 6% overall (with a sharp 14% drop in the healthcare/home environment category).

Margin leverage also continues to be elusive. Gross margin did finally improve, growing about 20 basis points from last year and 30 basis points from the previous quarter. Operating income was up less than 2%, however, and the operating margin slipped slightly.

SEE: Find Investment Quality In The Income Statement

Transitory Problems ... Or Deeper Issues?
Three months ago, I speculated that the company was seeing (or about to see) greater pressure from increased promotional activities at major rivals such as Procter & Gamble, Unilever and Clorox. And now management has acknowledged some of that impact, at least in the personal care division.

While Helen of Troy does enjoy good placement at major retailers like Walmart (NYSE:WMT) and Target (NYSE:TGT), it's hard to gain share against the market leaders like P&G, Unilever, Conair and Colgate-Palmolive (NYSE:CL), when they're willing to sacrifice revenue/gross margin to hold share. So even though Helen of Troy's relatively higher weighting toward value pricing ought to help, that competitive promotional activity makes life harder.

I have some longer-term worries about Helen of Troy as well. By and large, nobody sees much growth potential in the North American personal care market anymore; companies like P&G and Unilever are increasingly having to tout their emerging market exposure to maintain investor enthusiasm. That makes me wonder about the extent to which these large companies will continue to use promotional to maintain share and cash flow, while using overseas markets to drive growth.

SEE: Industry Handbook: Porter's 5 Forces Analysis

The Bottom Line
I don't believe Helen of Troy is finished building its business; as Spectrum Brands (NYSE:SPB) showed recently in its deal with Stanley Black & Decker (NYSE:SWK), there's almost always someone looking to sell consumer brands at a reasonable price. What I do worry about, though, is whether the company can deliver the margin and cash flow leverage that is so critical to the stock working on a long-term basis.

If Helen of Troy can continue to post mid-single digit growth and boost the free cash flow margin into the double digits by 2022, this stock ought to be worth something close to $40. If the free cash flow margin only moves into the high single-digits, the target drops to the low $30s. This stock has rewarded prudent aggressiveness in the past, and I think it will do so again - this is certainly a rough spot in the company's history, but I do believe 2013 could be a better year for the company and this stock is worth a spot on the watch list of more aggressive investors.

At the time of writing, Stephen D. Simpson did not own any shares in the companies mentioned.

Related Articles
  1. Investing News

    Today's Sell-off: Are We in a Margin Liquidation?

    If we're in market liquidation, is it good news or bad news? That party depends on your timeframe.
  2. Investing News

    Bank Stocks: Time to Buy or Avoid? (WFC, JPM, C)

    Bank stocks have been pounded. Is this the right time to buy or should they be avoided?
  3. Stock Analysis

    Why the Bullish Are Turning Bearish

    Banks are reducing their targets for the S&P 500 for 2016. Here's why.
  4. Stock Analysis

    How to Find Quality Stocks Amid the Wreckage

    Finding companies with good earnings and hitting on all cylinders in this environment, although possible, is not easy.
  5. Investing News

    What You Can Learn from Carl Icahn's Mistakes

    Carl Icahn has been a stellar performer in the investment world for decades, but following his lead these days could be dangerous.
  6. Stock Analysis

    Analyzing Altria's Return on Equity (ROE) (MO)

    Learn about Altria Group's return on equity (ROE) and analyze net profit margin, asset turnover and financial leverage to determine what is causing its high ROE.
  7. Investing News

    Icahn's Bet on Cheniere Energy: Should You Follow?

    Investing legend Carl Icahn continues to lose money on Cheniere Energy, but he's increasing his stake. Should you follow his lead?
  8. Stock Analysis

    Analyzing Google's Return on Equity (ROE) (GOOGL)

    Learn about Alphabet's return on equity. How has its ROE changed over time, how does it compare to its peers and what factors are driving ROE for the company?
  9. Investing News

    Is Buffett's Bet on Oil Right for You? (XOM, PSX)

    Oil stocks are getting trounced, but Warren Buffett still likes one of them. Should you follow the leader?
  10. Investing News

    Chipotle Served with Criminal Probe

    Chipotle's beat muted expectations and got a clear bill from the CDC, but it now appears that an investigation into its E.coli breakout has expanded.
RELATED FAQS
  1. How do dividends affect retained earnings?

    When a company issues a cash dividend to its shareholders, the retained earnings listed on the balance sheet are reduced ... Read Full Answer >>
  2. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  3. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  4. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>
  5. What types of capital are not considered share capital?

    The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>
  6. What is the difference between issued share capital and subscribed share capital?

    The difference between subscribed share capital and issued share capital is the former relates to the amount of stock for ... Read Full Answer >>
COMPANIES IN THIS ARTICLE
Trading Center